Philip A. Mudd
Impact in
- Infectious Diseases top 1%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Virology top 5%
- HIV Research and Treatment
Papers in
-
- COVID-19 Clinical Research Studies 21
- SARS-CoV-2 and COVID-19 Research 8
- Virology 7
- HIV Research and Treatment 7
- Co-authors
- Ali H. Ellebedy (12 shared papers)Jackson S. Turner (8 shared papers)Jane A. O’Halloran (13 shared papers)Amy Darise Farris (3 shared papers)Aaron J. Schmitz (4 shared papers)Kenneth E. Remy (3 shared papers)Rachel M. Presti (7 shared papers)Shirin Strohmeier (3 shared papers)
- Journals
- The Journal of Immunology (5 papers)Journal of Virology (5 papers)Immunity (4 papers)Allergy (2 papers)Nature (2 papers)
- Partner nations
- United StatesAustraliaMexico
In The Last Decade
Philip A. Mudd
54 papers receiving 2.9k citations
Philip A. Mudd's Hit Papers
Peers
Comparison fields: 5 of 98
- Infectious Diseases 1.3k
- Virology 246
- Immunology 502
- Aging 23
- Epidemiology 437
Countries citing papers authored by Philip A. Mudd
This map shows the geographic impact of Philip A. Mudd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip A. Mudd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip A. Mudd more than expected).
Fields of papers citing papers by Philip A. Mudd
This network shows the impact of papers produced by Philip A. Mudd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip A. Mudd. The network helps show where Philip A. Mudd may publish in the future.
Co-authors
The 25 scholars most cited alongside Philip A. Mudd, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 57 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Germinal centre-driven maturation of B cell response to mRNA vaccination Hit paper breakdown → | 2022 | 254 |
| 2 | 2020 | 251 | |
| 3 | 2021 | 234 | |
| 4 | 2020 | 228 | |
| 5 | 2019 | 202 | |
| 6 | 2021 | 193 | |
| 7 | 2012 | 154 | |
| 8 | 2021 | 152 | |
| 9 | 2021 | 131 | |
| 10 | 2020 | 100 | |
| 11 | 2021 | 97 | |
| 12 | 2021 | 97 | |
| 13 | 2020 | 70 | |
| 14 | 2020 | 61 | |
| 15 | 2007 | 54 | |
| 16 | 2021 | 50 | |
| 17 | 2010 | 49 | |
| 18 | 2006 | 47 | |
| 19 | 2021 | 41 | |
| 20 | 2023 | 36 |
About Philip A. Mudd
Philip A. Mudd is a scholar working on Infectious Diseases, Virology, Epidemiology, Immunology and Rheumatology, having authored 57 papers that have together received 3k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (21 papers), Influenza Virus Research Studies (12 papers), SARS-CoV-2 and COVID-19 Research (8 papers), HIV Research and Treatment (7 papers), T-cell and B-cell Immunology (5 papers), Mosquito-borne diseases and control (2 papers), Sepsis Diagnosis and Treatment (2 papers) and Systemic Lupus Erythematosus Research (2 papers). The work is most often cited by research in Infectious Diseases (1.3k citations), Virology (246 citations), Immunology (502 citations), Aging (23 citations) and Epidemiology (437 citations). Philip A. Mudd has collaborated with scholars based in United States, Australia and Mexico. Frequent co-authors include Ali H. Ellebedy, Jackson S. Turner, Jane A. O’Halloran, Amy Darise Farris, Aaron J. Schmitz, Kenneth E. Remy, Rachel M. Presti, Shirin Strohmeier, Florian Krammer and Meagan McMahon. Their work appears in journals such as The Journal of Immunology, Journal of Virology, Immunity, Allergy and Nature.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.